<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2021 (11) TMI 701 - ITAT MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=414920</link>
    <description>The Tribunal partly allowed the appeal, setting aside the disallowance of sales promotion expenses and directing the AO to delete the addition. Additionally, the AO was directed to verify and allow the credit for taxes paid. The Tribunal held that the CBDT Circular enlarging the scope of regulations cannot be applied retrospectively to pharmaceutical companies. The order was pronounced on 20.09.2021.</description>
    <language>en-us</language>
    <pubDate>Mon, 20 Sep 2021 00:00:00 +0530</pubDate>
    <lastBuildDate>Sat, 20 Nov 2021 09:55:44 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=661638" rel="self" type="application/rss+xml"/>
    <item>
      <title>2021 (11) TMI 701 - ITAT MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=414920</link>
      <description>The Tribunal partly allowed the appeal, setting aside the disallowance of sales promotion expenses and directing the AO to delete the addition. Additionally, the AO was directed to verify and allow the credit for taxes paid. The Tribunal held that the CBDT Circular enlarging the scope of regulations cannot be applied retrospectively to pharmaceutical companies. The order was pronounced on 20.09.2021.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Mon, 20 Sep 2021 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=414920</guid>
    </item>
  </channel>
</rss>